Investigation reveals new compounds with pharmacological activity in musk from Siberian musk deer, indicating biomedical potential.
This study presents the results of an investigation into minor biologically active compounds in extracts of Siberian musk deer (Moschus moschiferus) musk using high-performance liquid chromatography coupled with high-resolution mass spectrometry. A qualitative and semi-quantitative analysis was performed on various components, including steroids, terpenoids, peptides, and low-molecular-weight organic compounds with potential pharmacological activity. Several compounds, previously unidentified in this biological material, were detected, enhancing our understanding of the chemical composition of musk deer musk and its potential applications in biomedicine.
No takes yet. Share an insight, caveat, or question.
Nesterov et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: